Main Menu

Clinical Academic Radiotherapy Team (Dearnaley)

Professor David Dearnaley’s team are researching ways to better target a tumour during radiotherapy while avoiding healthy tissue around it.

Team leader

Professor David Dearnaley

Professor David Dearnaley

Professor David Dearnaley has been central to the development of intensity modulated radiotherapy – a new radiotherapy technique that reduces damage to healthy tissue. He is currently running several trials for treating prostate cancer and is investigating new image-guided radiotherapy techniques.

ORCID 0000-0002-3954-2806

Team members

Dr Sarah Gulliford

Staff Scientist